Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 9 trials

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

5Total
Not Applicable (2)
P 2 (2)
P 3 (1)

Trial Status

Not Yet Recruiting6
Enrolling By Invitation1
Recruiting1
Unknown1

Clinical Trials (9)

Showing 9 of 9 trials
NCT06504576Phase 2RecruitingPrimary

Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage

NCT06587737Phase 3Not Yet Recruiting

Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage

NCT07316270Not ApplicableNot Yet Recruiting

SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracerebral Hemorrhage (SAFER-AF)

NCT07162363Phase 2Not Yet Recruiting

Synergistic Minimally Invasive Surgery and Deferoxamine in ICH

NCT07042048Not ApplicableNot Yet RecruitingPrimary

Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization

NCT05611918Enrolling By Invitation

REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

NCT06654544Not Yet RecruitingPrimary

Epidemiology of Intracerebral Hemorrhage

NCT06490978Not Yet RecruitingPrimary

Predictors of Early Hematoma Expansion in Patients With Acute Intracerebral Hemorrhage (Clinical and Laboratory Study)

NCT04728438Unknown

Effect of Targeted Temperature Management on Cerebral Autoregulation in Patients With Neurocritical Diseases

Showing all 9 trials

Research Network

Activity Timeline